Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Rajewski

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|October 27, 2004
Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs)Kazuto Okimoto, Yuji Tokunaga, Rinta Ibuki, et al.
Cancer Chemotherapy and Pharmacology|September 17, 2009
Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeysIzet M Kapetanovic, Miguel Muzzio, Shu-Chieh Hu, et al.
Journal of Pharmaceutical Sciences|April 3, 2008
Pharmacokinetics of DS-96, an alkylpolyamine lipopolysaccharide sequestrant, in rodentsAnurupa Shrestha, Rongti Li, Diptesh Sil, et al.
Gynecologic Oncology|March 20, 2018
Small molecule inhibition of the CBFβ/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transitionAnne L Carlton, Anuradha Illendula, Yan Gao, et al.
ASN Neuro|August 17, 2010
Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic miceMichael J Urban, Chengyuan Li, Cuijuan Yu, et al.
Molecular Cancer Therapeutics|January 5, 2013
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft modelSuman Kambhampati, Roger A Rajewski, Mehmet Tanol, et al.
Journal of Medicinal Chemistry|May 11, 2011
Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agentsHuiping Zhao, Alison C Donnelly, Bhaskar R Kusuma, et al.
Leukemia & Lymphoma|December 19, 2017
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cellsZaw Min Oo, Anuradha Illendula, Jolanta Grembecka, et al.
Assay and Drug Development Technologies|October 17, 2013
Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitorsTakrima Sadikot, Megan Swink, Jeffery D Eskew, et al.
Science (New York, N.Y.)|February 14, 2015
Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in miceAnuradha Illendula, John A Pulikkan, Hongliang Zong, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|October 27, 2004
Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs)Kazuto Okimoto, Yuji Tokunaga, Rinta Ibuki, et al.
Cancer Chemotherapy and Pharmacology|September 17, 2009
Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeysIzet M Kapetanovic, Miguel Muzzio, Shu-Chieh Hu, et al.
Journal of Pharmaceutical Sciences|April 3, 2008
Pharmacokinetics of DS-96, an alkylpolyamine lipopolysaccharide sequestrant, in rodentsAnurupa Shrestha, Rongti Li, Diptesh Sil, et al.
Gynecologic Oncology|March 20, 2018
Small molecule inhibition of the CBFβ/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transitionAnne L Carlton, Anuradha Illendula, Yan Gao, et al.
ASN Neuro|August 17, 2010
Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic miceMichael J Urban, Chengyuan Li, Cuijuan Yu, et al.
Molecular Cancer Therapeutics|January 5, 2013
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft modelSuman Kambhampati, Roger A Rajewski, Mehmet Tanol, et al.
Journal of Medicinal Chemistry|May 11, 2011
Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agentsHuiping Zhao, Alison C Donnelly, Bhaskar R Kusuma, et al.
Leukemia & Lymphoma|December 19, 2017
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cellsZaw Min Oo, Anuradha Illendula, Jolanta Grembecka, et al.
Assay and Drug Development Technologies|October 17, 2013
Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitorsTakrima Sadikot, Megan Swink, Jeffery D Eskew, et al.
Science (New York, N.Y.)|February 14, 2015
Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in miceAnuradha Illendula, John A Pulikkan, Hongliang Zong, et al.
Pageof 3